Professor, Department of Pathology, Director of the Toxicology Laboratory, Associate Director of the Clinical Chemistry Lab, University of California, San Diego
BIOGRAPHY
DEC 09, 2015 10:00 AM PST
Share
WEBINAR: Emerging Trends in Heart Failure Therapy and the Importance of Natriuretic Peptides
Speaker
Abstract
Date: December 9, 2015 10AM Pacific, 1PM Eastern
July 7, 2015, the U.S. Food and Drug Administration reviewed and approved ENTRESTO™ (sacubitril/valsartan) tablets to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. This important news could shift the paradigm in the way heart failure patients will be managed using NT-proBNP in lieu of BNP for patients receiving ENTRESTO™.
In this webinar, we will discuss the analytical and clinical considerations of NT-proBNP testing and the impact of ENTRESTO™ on biomarker testing.
Learner Objectives:
• Describe differences in stability of NT-proBNP and BNP
• Describe the analytical differences between NT-proBNP and BNP assays
• Describe how natriuretic peptides compare in the setting of renal failure
• Describe the mechanism of action of ENTRESTO™ and it’s effect on natriuretic peptides
July 7, 2015, the U.S. Food and Drug Administration reviewed and approved ENTRESTO™ (sacubitril/valsartan) tablets to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. This important news could shift the paradigm in the way heart failure patients will be managed using NT-proBNP in lieu of BNP for patients receiving ENTRESTO™.
In this webinar, we will discuss the analytical and clinical considerations of NT-proBNP testing and the impact of ENTRESTO™ on biomarker testing.
Learner Objectives:
• Describe differences in stability of NT-proBNP and BNP
• Describe the analytical differences between NT-proBNP and BNP assays
• Describe how natriuretic peptides compare in the setting of renal failure
• Describe the mechanism of action of ENTRESTO™ and it’s effect on natriuretic peptides
You May Also Like
SEP 28, 2022
9:00 AM PDT
SEP 28, 2022
9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
SEP 29, 2022
11:00 AM PDT
SEP 29, 2022
11:00 AM PDT
Date: September 29, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Pharmacogenomic (PGx) testing is a dynamic and fascinating application for genetic testing. We'll review the bas...
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
OCT 12, 2022
9:00 AM PDT
C.E. CREDITS
OCT 12, 2022
9:00 AM PDT
Date: October 12, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) The microbiome of every food product is incredibly diverse and can include everything from innocuous background flora...
NOV 16, 2022
7:00 PM PST
C.E. CREDITS
NOV 16, 2022
7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
Loading Comments...
Finish Registering
-
JAN 31, 20232023 Virtual xMAP® Connect -
MAR 08, 2023Neuroscience Virtual Event Series 2023
-
MAR 22, 2023Laboratory Automation Virtual Event Series 2023
-
APR 05, 2023Bioprocessing Virtual Event Series 2023
- See More
-
JAN 26, 2023
-
JAN 26, 2023
-
JAN 26, 2023
- See More
